Mabl vs Testim: the self-healing locator incumbents in 2026.

What each platform actually delivers

Mabl is a SaaS end-to-end testing platform with a low-code authoring UI, self-healing locator engine, and a published focus on continuous testing in CI pipelines. The vendor page (mabl.com) positions the product around test-creation speed, locator stability, and integration with the modern devops stack. Mabl is independent and venture-backed; its strategic decisions are not gated by a parent company's platform priorities.

Testim was acquired by Tricentis in late 2021 and is now sold as part of the Tricentis platform family (tricentis.com/products/testim). The product itself remains a self-healing end-to-end platform with a recorder-first authoring model, but the procurement context is different: Testim is often quoted as part of a broader Tricentis platform conversation that may include Tosca, qTest, and other Tricentis products. For a customer that already runs Tosca, that bundling can be an advantage; for a customer that wants a single-purpose end-to-end tool, it can complicate the conversation.

Self-healing as a category, not a feature

Both products implement self-healing using a similar pattern: when a primary locator fails (a CSS selector or XPath that no longer resolves), the runner falls back to alternative identifiers (accessibility labels, text content, structural neighbours, AI-described element fingerprints) and continues the test. The success rate of the fallback depends on how the original test was authored and how dramatically the application has changed. Both vendors publish "tests survived" statistics from customer case studies; neither publishes an independent benchmark, and neither comparison should rely on those numbers as if they were independent.

For a deeper discussion of what self-healing can and cannot do, see the self-healing tests category page. Both Mabl and Testim are listed there alongside Functionize and Reflect; the same category page covers the published mechanism trade-offs in more detail than this comparison does.

Authoring model

Mabl's authoring centres on a browser-based authoring tool plus a Chrome trainer for recording. Tests are stored as a structured representation, and the platform's low-code interface lets non-engineers author and maintain flows. The vendor positions this as enabling QA engineers to author tests without writing Selenium or Playwright code.

Testim's authoring is similarly recorder-led, with a smart locator engine that captures multiple identifiers for each element. The visual editor supports steps that are reusable across tests; the published examples emphasise reusability across regression suites. Both products produce test artefacts that live in the vendor platform; neither produces standalone Playwright code in the way QA Wolf does.

CI integration

Both vendors document integration with the major CI runners (GitHub Actions, GitLab CI, CircleCI, Jenkins). The published patterns are similar: a webhook or runner action triggers a test execution, results are posted back to the PR or pipeline, and failed runs link to a hosted result view inside the vendor platform. Neither runs natively inside the CI runner itself; execution happens in vendor cloud (or a vendor-managed runner) and results are posted back.

Pricing and procurement

Neither vendor publishes per-seat or per-test pricing on its public site as of April 2026. Both quote custom enterprise contracts scoped to test volume, parallelisation, environment count, and seat count. The procurement implication is that buyers should expect a multi-week sales cycle for either product and should compare on total cost of ownership rather than list price.

The Tricentis context for Testim is the distinctive variable. A buyer that is also evaluating Tricentis Tosca, qTest, or other Tricentis products may get a better effective rate on Testim through bundling. A buyer with no other Tricentis interest is paying for a single product line under a multi-product company; that can be neutral or negative depending on the vendor's engagement model.

Strategic durability

Mabl's independence is a feature for buyers that value a focused roadmap; it is also a risk in that any single-product venture company can change ownership. Testim's position inside Tricentis is the inverse: the strategic durability of the product line is tied to Tricentis' portfolio decisions, which gives buyers confidence about long-term support but introduces dependency on Tricentis' broader direction. Neither risk is large in 2026; both should be acknowledged in a procurement decision that is intended to last 3 to 5 years.

Where each loses to newer entrants

Both Mabl and Testim are excellent self-healing platforms and both have added AI-assisted authoring features. Neither is positioned as a full agentic end-to-end product in the way Meticulous or Momentic are positioned. Buyers who specifically want session-replay regression (Meticulous) or natural-language agentic authoring (Momentic) will not find that exact shape in Mabl or Testim. Conversely, teams that want a mature platform with a deep customer base and an established services ecosystem will not find that maturity in the newer entrants.

How to choose

The honest framing: if your team already runs Tricentis Tosca or qTest, Testim is the obvious procurement-led answer. If your team values strategic independence and a focused roadmap, Mabl is the cleaner answer. If neither of those is decisive, the call comes down to the pilot results on your specific application; both vendors will pilot, and a one-week parallel pilot on a representative flow set is the right way to break the tie.

Frequently asked questions

Is Testim still sold separately after the Tricentis acquisition?

Yes. Testim continues to be marketed and sold as a Tricentis product, with the vendor page now hosted under the tricentis.com domain. Pricing remains custom enterprise per the published pages and is most often quoted as part of broader Tricentis platform conversations.

Is Mabl SOC 2 attested?

Mabl's trust page describes SOC 2 Type II attestation, alongside other compliance evidence available on request. Buyers in regulated industries should confirm the current attestation letter date during procurement rather than relying on a marketing claim.

Which one fits better for a non-engineering test author?

Both are designed for low-code authoring with self-healing locators. The published interfaces differ in detail but both reduce the learning curve compared with raw Playwright or Selenium. The right one for a non-engineering author is the one that handles their specific authoring patterns; both vendors offer trials and the question is best answered by running the actual flows.

What is the difference between self-healing and AI-generated tests?

Self-healing means an existing test continues to run when a locator changes, by falling back to alternative selectors. AI-generated means a tool produces a test from scratch given a goal or recording. Both Mabl and Testim are primarily self-healing platforms; they have some AI-assisted authoring features but the core value proposition is keeping existing tests alive through application change.

What about Functionize or Reflect?

Both Functionize and Reflect occupy the same category. Reflect publishes self-serve pricing tiers; Functionize is custom enterprise. The Mabl-vs-Testim comparison is the most common buyer pairing because both are mid-to-large-enterprise incumbents with overlapping target customers.